Back

Distinct pathophysiological pathways in women and men with heart failure

21 May 2022 (11:55 - 12:10)
Organised by:
Congress Presentation Part of: Young Investigator Award: clinical research Pathophysiology HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Alice Ravera

Civil Hospital of Brescia, Brescia (Italy)

3 More presentations in this session

Presentation thumbnail
Discontinuation of guideline-recommended heart failure treatments after a first hospitalization for heart failure - An analysis from the SwedeHF registry
Abstract Slides
Presentation thumbnail
Efficacy and safety of dapagliflozin according to frailty in heart failure with reduced ejection fraction: a post hoc analysis of the DAPA-HF trial
Doctor J. Butt (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
The effect of dapagliflozin according to iron status and its effect on iron metabolism: insights from DAPA-HF
Doctor K. Docherty (Glasgow, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award: clinical research
Video

The Event

Event poster

Heart Failure 2022

21 May 2022 11:55 CET
You may be interested in
thumbnail
Congress Presentation
Decoding heart failure through plasma proteomics: differential protein signatures across the ejection fraction spectrum with sex-specific insights
31 August 2025
thumbnail
Congress Session
Heart failure in women: causes, consequences, and treatment
26 August 2022
thumbnail
Congress Presentation
Sex differences in effects of pharmacological treatment of heart failure: a meta-analysis and meta-regression of randomized controlled trials
30 August 2025
thumbnail
Congress Presentation
Why sex is important: sex differences in pre-clinical models
14 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources